| |
Bruce Scott, MBA
CEO/Principal
Menlo Park, CA
Bruce has engineered over 70 deals involving licensing, collaborations, M&A, and corporate partnerships. Bruce has experience in general management, finance, fund raising, licensing, business development, corporate strategy, M&A, and launching new businesses. Industries worked in include: life sciences, advanced materials, chemistry, nanotechnology and information technology. Companies he has been associated with include: Nuada Pharmaceuticals, Geron Corporation, NovoDynamics, Catalytica Advanced Technologies and Energy Systems, AIM Nutraceuticals, BF Goodrich and NovoTec. Bruce has an MBA from Purdue University and a B.S. in Public Accounting from Gonzaga University.
Top
David Deacon, Ph.D.
President, Dagamite Corp.
Los Altos, CA
Dr. Deacon has almost 30 years of business development and technology experience in a range of spaces, especially physics-based technologies. Dr. Deacon excels in helping entrepreneurs grow their company, raise funds and exit profitably. He has a proven track record of refining business plans, driving due diligence processes, connecting companies with potential buyers (especially in Silicon Valley) and closing investment rounds. Dr. Deacon started his career by developing an e-beam accelerator based laser and free electron laser technologies. He then started his own business, building a portfolio of patents and a business that grew annual revenue an average of 46% for 12 consecutive profitable years. He then sold this business to Gemfire Corp., where he became CEO, CTO and a Member of the Board. He then became CEO, CTO and Chairman for Sparkolor Corp., before launching Dagamite. Dr. Deacon is also a member of the Band of Angels in Silicon Valley and a member of Silicon Ventures. . Dr. Deacon earned a BS in Physics and Electrical Engineering at the Massachusetts Institute of Technology and a Ph.D. in Physics at Stanford University.
Top
Bradford W. Baer, Ph.D.
Principal BioDirections
Palo Alto, CA
Dr. Baer has over 22 years of experience in the biotech industry. His expertise lies in therapeutic development, pre-clinical projects, technology acquisition, raising capital fund and product development. He has raised over $16M in venture money, initiated significant worldwide trials and been Owner/Senior Manager/CEO of companies like Cetus Corp., Angiogenix, Darwin Molecular and Fluidigm. Dr. Baer received his B.A. with highest honors in Biology and Chemistry from the University of California at Santa Cruz, his Ph.D. in Biological Chemistry from Harvard University, and was a postdoctoral fellow and staff scientist at the Medical Research Council in Cambridge, England.
Top
Edward Beardsworth
Consultant
Palo Alto, CA
Dr. Beardsworth is a marketing strategy and business development expert with over twenty five years in the electric utility and energy industry. His interdisciplinary strengths combine both technical and business planning perspectives. Dr. Beardsworth works with utilities individually and in a collaborative manner to help them with technology strategies and business development and structures. He is a strategic advisor to Nth Power, the leading venture capital fund that specializes in energy utility-related technology. Prior to entering private consulting in 1992, he was at the Electric Power Research Institute, as a Project Manager, then in a corporate marketing and R&D technology transfer role. Dr. Beardsworth also worked at the Brookhaven National Lab prior to joining EPRI. He received his Ph.D. in Physics from Rutgers University
Top
Robert Burmeister, Ph.D.
Director of Business Development
Saratoga, CA
Dr. Burmeister has more than 25 years experience in photonics, optics, fiber optic components and other high technologies. He currently assists Fortune 500 and start-up companies in technology commercialization. Prior to this he was the founding Director of the US-Japan Technology Management Center at Stanford University; established as a center of excellence in technology management research and education related to Japan. He was also Consulting Professor of Electrical Engineering at Stanford with special interest in advanced optoelectronics. He spent 20+ years at the Hewlett-Packard Company in Palo Alto, California, where he held a number of technical and management positions of increasing responsibility including Director of the Materials Research Laboratory in Hewlett-Packard Laboratories. He has been responsible for advanced R&D of a broad range of electronic and optoelectronic materials and devices, including LEDs, semiconductor lasers, fiber optic devices, and their subsequent commercialization. Dr. Burmeister received his B.S. from the University of Wisconsin, and his M.S. and Ph.D. degrees in Materials Science from Stanford University.
Top
Rock Clapper, Ph.D
Investor and entrepreneur specializing in social networking. Founder and/or CEO of multiple web based
companies including School Time Software (sold to School Time Concepts 1998) and GotSavings.com
(prepared for IPO in 2000). Experience with web-based consumer and business environments, persuasive
communication, M&A transactions. Currently Director at Producepoint.com, divinR.com, nTangle.com,
and Raendance.com. Professor, Brown University Medical School, PhD Applied Social Psychology, Brown.
Member, Band of Angels, Association of Corporate Growth (Silicon Valley).
Top
John Didsbury, Ph.D.
President/Chief Executive Officer Nuada Pharmaceuticals Inc.
Research Triangle Park, NC
Dr. Didsbury has over 18 years of executive management experience within pharmaceutical and biotechnology industries. He has taken 3 drug discovery programs to selection of clinical candidate molecules within 14 months by raising $10 Million. Dr. Didsbury has been associated the following companies: Nuada Pharmaceuticals (CEO), GlaxoSmithKline, Macronex, Genentech and Duke University Medical Center. He earned his B.A. in Biology/Chemistry at University of Connecticut in 1977 and his Ph.D. in Medical Microbiology at University of Vermont Medical College in 1982.
Top
Eric Evitt, Ph.D.
Consultant
Mountain View, CA
Dr. Evitt has more than 20 years of catalysis, chemical and chemical process R&D and R&D management. His expertise includes intellectual property assessment, process development and inter-company joint R&D. Dr. Evitt has spent more than 14 years at Catalytica in various positions, including Senior Management. Dr. Evitt completed his B.S. in Chemistry from the University of Rochester and his Ph.D. in Chemistry from the California Institute of Technology. He then was a Post-doctoral Fellow at Stanford University.
Top
Christine Faraci, MBA
Business Development - High Technology
San Francisco, CA
Ms. Faraci has over 12 years experience working in the information technology industry with combined experience in telecommunications, business applications, and enterprise networking. As Regional Vice President for the Yankee Group, Ms. Faraci was responsible for business development for telecommunications and enterprise networking market research and consulting engagements. Previous to that she spent six years implementing financial services applications including risk management tools and trading systems. Ms. Faraci educational background includes an MBA in MIS from Loyola University in Chicago and a B.S. in Public Communications from Syracuse University.
Top
Ted Gomoll, MBA
CFA
Mill Valley, CA
Ted has over 35 years of investment industry experience. His professional experience includes over 25 years in portfolio management concentrating on the health care industry. He established one of the first global health care mutual funds while with G T Capital Management in San Francisco. Ted was Director of Research for a regional west coast brokerage firm. Ted has also been actively engaged in private equity and venture capital during his investment career. Several notable investments were: ACS which became Guidant, subsequently acquired by Boston Scientific; Concept which was acquired by Bristol Myers, and is now a part of Zimmer; Arterial Vascular which was acquired by Medtronic; Corr Therapeutics which was acquired by Mellenium and SCIOS which was acquired by Johnson & Johnson. Ted has assisted in over 25 financing transactions over the past 30 years, thus helping emerging drug and medical technology companies raise growth c apital. He has also advised on various merger transactions within the health care industry. Ted is a Chartered Financial Analyst. Ted has a BA in Economics from Colgate University, an MBA from the Tuck School and an MS in Finance from the Stern School.
Top
Jan Lerou, Ph.D.
Operational Executive Velocys
Columbus, OH
Dr. Lerou has nearly 30 years of experience in leading catalysis, process engineering and experimental programs in the chemical and informatics industries. He was CTO of NovoDynamics, a molecular discovery informatics company and held many senior management positions at DuPont. He has a B.S. in Chemical Engineering from the Catholic University Leuven, and a Ph.D. from the University of Gent, both of which are in Belgium.
Top
Nola Masterson
Managing Director Science Futures, Inc.
San Francisco, CA
Ms. Masterson has 30+ years of experience in the life sciences and venture capital investment. She serves as the Managing Director of Science Futures Inc., a life sciences venture capital firm with three fully invested funds. In addition, she opened the San Francisco office of Techno Venture Management (TVM), one of the first venture capital firms in Germany and one of the largest in Europe. Ms. Masterson was a founding president of Sequenom Inc., where she laid the groundwork for subsequent financings and the company’s IPO. Other companies she has been associated with are IDEC Pharmaceuticals, NanoStream, Pain Therapeutics, MediGene, a life sciences Hedge fund, and many other early stage companies. Ms. Masterson is a board member of Zonagen, Inc., a publicly traded biotech company, and of Omicia, an early-stage pharmacogenomics company. She earned a B.S. in Biology and Chemistry from Marymount College, a M.Sc. in biological sciences from George Washington University, and completed doctoral course work in Molecular Biology at the University of Florida.
Top
Masato (Marty) Matsuo, Ph.D.
President and CEO of USJP Technology, Inc.
Los Gatos, CA
Dr. Matsuo has over 30 years of business development experience for a Japanese chemical company, where he served as Chief Technology Officer. His focal area has been for applications of polymers, medical devices (especially cardio-vascular devices), electronic chemicals used in semiconductor packaging and photo-resists, polymer batteries, silicon wafer slicing technologies and bio-technology (including DNA vaccines). He has completed over 20 licensing and joint research agreements, which lead to product sales of $400 million. Dr. Matsuo is currently the President and CEO of USJP Technology, Inc., a consulting company with the focus of bridging technologies between the US and Japan. He is also active in education as the Professor and Director of Kyushu University California Office and in a volunteer work, which includes Board of Trustee of Hakone Foundation and Japanese University Network in the Bay Area. Dr. Matsuo received B.S., M.S. and Ph.D. degrees in polymer science from Kyushu University in Japan, where he is currently professor.
Top
Maurice F. McCarthy, Jr., M.D.
Consultant
Orlando, FL
Dr. McCarthy has 20+ years experience as a physician specializing in Rheumatology. His research has encompassed DMARD Therapy in patients with Rheumatoid Arthritis and post operative spinal fluid infection after neurosurgical shunting procedure. Dr. McCarthy currently serves as active staff for the Winter Haven Hospital in the Gessler Clinic, P.A. His certifications include American Board of Internal Medicine – Diplomate, Certified Clinical Densitometrist, International Society for Clinical Densitometry and American College of Rheumatology. Dr. McCarthy completed his residencies and internship at the University of Miami and his doctorate at University of Virginia School of Medicine. His undergraduate work was completed at Emory University.
Top
Jack W. Moorman
Consultant
San Jose, CA
Mr. Moorman has over 30 years of experience in Medical Device/Instrumentation, Nanotechnology and Semiconductor related businesses. The other 10 plus years has been in medical devices and biotech instrumentation. He has been the founder of seven companies and been the president of a publicly traded semiconductor equipment company, Nanometrics, Inc. Mr. Moorman has led multiple financing rounds. Mr. Moorman received a B.S. in Engineering from the University of Illinois and a Masters in Management from Stanford Business School.
Top
Laura Raynak
Executive Recruiter
Santa Cruz, CA
Laura's background in sales, marketing, and retained executive search has given her the necessary skills to achieve exceptional results for her clients in the selection and retention of senior executives. Her skills have resulted in the placement of successful executives in many, financial Services, biotechnology, medical devices and consumer products. Laura earned a BA degree in Biochemistry & Molecular Biology from the University of California, Santa Cruz. She also holds a Certificate in Human Resources Management from the UC Extension, and is a board member of NCHRA, ADA and The Institute of Management Consultants. She is also an active member of ACG, Forum for Women Entrepreneurs, Churchill Club, and National Association of Corporate Directors.
Top
Vivian Ting, MD, FACS
Ms. Ting has been practicing medicine and cosmetic & micro-surgery for 15 years. She currently practices cosmetic surgery in Walnut Creek, California and is an Assistant Clinical Professor in the Department of Surgery at the University of California San Francisco School of Medicine. She also sits on the Medical Executive Committee for the Aspen Surgical Center. She is licensed in four states, has two Board Certifications and hospital privileges at five area hospitals. She is also trained in advanced trauma and cardiac life support and is a member of several professional societies. She has also made several publications in her areas of expertise. Ms. Ting’s educational background includes an A.B. in Biology, Magna cum laude, from Harvard University and an M.D. from the University of Pennsylvania School of Medicine.
Top
Richard Wilmuth, Ph.D.
Consultant
Menlo Park, CA
Dr. Wilmuth has been developing software and running his own successful business for over 30 years. Dr. Wilmuth performs management consulting in business and government in the areas of financial analysis, budgeting, human resources, information management, application systems, quantitative analysis and decision-making support. He has developed an extensive corporate financial planning and modeling tool for Silicon Valley companies and performs object-oriented programming in C++, Microsoft SQL Server Database and Windows application development tools. Dr. Wilmuth holds special knowledge in management science in linear/non-linear programming, data analysis, decision analysis, stochastic systems, solution modeling, and related software systems research and development. He earned his Ph.D. in Operations Research from Stanford University and holds a B.S. and an M.S. in EECS from the University of California at Berkeley.
Top
Linda X. Zhao, Ph.D./MBA
President & CEO of Draco Healthcare Consulting, LLC
Fremont, CA
Dr. Zhao has more than 20 years experience in biotech and pharmaceutical industries in China, Japan and the United Stated. Most recently, she was a leading consultant for the Japan oncology market at the MattsonJack Group, a global healthcare consultancy within WPP. She led many consulting projects for multinational pharmaceutical companies such as Pfizer, GSK, Novartis, Amgen as well as mid-sized biotech companies such as Biogen Idec, Dendreon. She has expertise in product testing, pricing/reimbursement, competitive intelligence, due diligence, in/out licensing, product pipeline assessment. Dr. Zhao is an established expert on the Asian healthcare market. She has published many review articles about China healthcare market in leading healthcare magazines such as “Scrip” and “MedTech Insight”. She is a frequent speaker at national and international conferences. As a co-founder and CEO of Draco Healthcare Consulting, LLC, she is committed to provide top-quality service for pharmaceutical and biotech companies who have interest in the healthcare market of the Greater China region. Dr. Zhao holds a Ph.D. degree of Molecular Biology from Purdue University, Indiana, USA and a MBA in Marketing from the California State University Hayward.
|
|
